rs371454519
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001278444.2(ANKLE1):c.1763G>T(p.Cys588Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,012,124 control chromosomes in the GnomAD database, including 1,458 homozygotes. In-silico tool predicts a benign outcome for this variant. 5/5 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001278444.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKLE1 | NM_152363.6 | c.*132G>T | 3_prime_UTR_variant | 9/9 | ENST00000404085.7 | NP_689576.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKLE1 | ENST00000404085.7 | c.*132G>T | 3_prime_UTR_variant | 9/9 | 2 | NM_152363.6 | ENSP00000384008.3 |
Frequencies
GnomAD3 genomes AF: 0.102 AC: 11660AN: 114518Hom.: 562 Cov.: 26
GnomAD3 exomes AF: 0.0805 AC: 5869AN: 72870Hom.: 119 AF XY: 0.0801 AC XY: 3057AN XY: 38158
GnomAD4 exome AF: 0.129 AC: 116096AN: 897520Hom.: 893 Cov.: 28 AF XY: 0.128 AC XY: 55880AN XY: 438002
GnomAD4 genome AF: 0.102 AC: 11667AN: 114604Hom.: 565 Cov.: 26 AF XY: 0.0987 AC XY: 5505AN XY: 55762
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Outside ROI, Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at